Cargando…
Pharmacological Interactions in the Elderly
Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect dr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404696/ https://www.ncbi.nlm.nih.gov/pubmed/32605319 http://dx.doi.org/10.3390/medicina56070320 |
_version_ | 1783567168460292096 |
---|---|
author | Błeszyńska, Emilia Wierucki, Łukasz Zdrojewski, Tomasz Renke, Marcin |
author_facet | Błeszyńska, Emilia Wierucki, Łukasz Zdrojewski, Tomasz Renke, Marcin |
author_sort | Błeszyńska, Emilia |
collection | PubMed |
description | Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy. |
format | Online Article Text |
id | pubmed-7404696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74046962020-08-11 Pharmacological Interactions in the Elderly Błeszyńska, Emilia Wierucki, Łukasz Zdrojewski, Tomasz Renke, Marcin Medicina (Kaunas) Review Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy. MDPI 2020-06-28 /pmc/articles/PMC7404696/ /pubmed/32605319 http://dx.doi.org/10.3390/medicina56070320 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Błeszyńska, Emilia Wierucki, Łukasz Zdrojewski, Tomasz Renke, Marcin Pharmacological Interactions in the Elderly |
title | Pharmacological Interactions in the Elderly |
title_full | Pharmacological Interactions in the Elderly |
title_fullStr | Pharmacological Interactions in the Elderly |
title_full_unstemmed | Pharmacological Interactions in the Elderly |
title_short | Pharmacological Interactions in the Elderly |
title_sort | pharmacological interactions in the elderly |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404696/ https://www.ncbi.nlm.nih.gov/pubmed/32605319 http://dx.doi.org/10.3390/medicina56070320 |
work_keys_str_mv | AT błeszynskaemilia pharmacologicalinteractionsintheelderly AT wieruckiłukasz pharmacologicalinteractionsintheelderly AT zdrojewskitomasz pharmacologicalinteractionsintheelderly AT renkemarcin pharmacologicalinteractionsintheelderly |